PRILOSEC (omeprazole) Delayed Release Capsules PRILOSEC (omeprazole magnesium) For Delayed Release Oral suspension

 PRILOSEC 10 MG CAPSULE DR

PRILOSEC 10 MG CAPSULE DR

Adult Min/Max Dose: 7.713mg/360.0mg
Pediatric Min/Max Dose: 0.2mg/kg/3.5mg/kg

Common Dosages by Indication:

Duodenal Ulcer
Duodenal Ulcer due to H. Pylori
Erosive Esophagitis
Gastric Hypersecretory Conditions
Gastric Ulcer
Gastroesophageal Reflux
Multiple Endocrine Adenoma
NSAID-Induced Duodenal Ulcer
NSAID-Induced Gastric Ulcer
Systemic Mastocytosis
Zollinger-Ellison Syndrome

All Labeled Uses: Duodenal Ulcer, Duodenal Ulcer due to H. Pylori, Erosive Esophagitis, Gastric Hypersecretory Conditions, Gastric Ulcer, Gastroesophageal Reflux, Maintenance of Healing Erosive Esophagitis, Multiple Endocrine Adenoma, NSAID-Induced Duodenal Ulcer, NSAID-Induced Gastric Ulcer, Prevention of Stress Ulcer, Systemic Mastocytosis, Zollinger-Ellison Syndrome
Unlabeled Uses: Fatty Stool as Cystic Fibrosis Intestinal Manifestation, Prevention of NSAID-Induced Gastric Ulcer, Upper GI Bleed

PREVACID (lansoprazole) Delayed-Release Capsules PREVACID (lansoprazole) For Delayed-Release Oral Suspension PREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets

 PREVACID 15 MG CAPSULE DR

PREVACID 15 MG CAPSULE DR

Adult Min/Max Dose: 6.75mg/90.0mg
Pediatric Min/Max Dose: 7.5mg/30.0mg

Common Dosages by Indication:

Duodenal Ulcer
Duodenal Ulcer due to H. Pylori
Erosive Esophagitis
Gastric Ulcer
Gastroesophageal Reflux
Maintenance of Healing Duodenal Ulcer
Maintenance of Healing Erosive Esophagitis
NSAID-Induced Gastric Ulcer
Prevention of NSAID-Induced Gastric Ulcer
Zollinger-Ellison Syndrome

All Labeled Uses: Duodenal Ulcer, Duodenal Ulcer due to H. Pylori, Erosive Esophagitis, Gastric Ulcer, Gastroesophageal Reflux, Maintenance of Healing Duodenal Ulcer, Maintenance of Healing Erosive Esophagitis, NSAID-Induced Gastric Ulcer, Pathological Gastric Hypersecretory Condition, Prevention of NSAID-Induced Gastric Ulcer, Zollinger-Ellison Syndrome
Unlabeled Uses: Prevention of Stress Ulcer, Upper GI Bleed

Contraindicated Drug Combination:
Clearly contraindicated in all cases and should not be dispensed or administered to the same patient:
PROTON PUMP INHIBITORS/ATAZANAVIR; NELFINAVIR - Decreased effect of the latter drug
Severe Interaction:
Action is required to reduce the risk of severe adverse interaction.
H2 ANTAGONISTS; PROTON PUMP INHIBITORS/RALTEGRAVIR -
H2 BLOCKERS & PROTON PUMP INHIBITORS/DASATINIB; ERLOTINIB -
PROTON PUMP INHIBITORS/SELECTED AZOLE ANTIFUNGALS - Decreased effect of the latter drug

PREMPRO™,PREMPHASE® (conjugated estrogens/medroxyprogesterone acetate) Tablets

Brand names Premphase®, Prempro®

Brand names Premphase®, Prempro®

USES:
This medication is used to reduce menopause symptoms. It helps reduce episodes of flushing and sweating of the upper body and face, commonly called hot flashes. It also helps treat dryness, itching, and burning around the vagina. These symptoms occur when a woman’s body no longer makes the usual amount of female hormone (estrogen). This medication is a combination of 2 types of female hormones: estrogen (conjugated estrogens) and a progestin (medroxyprogesterone). A progestin is added to estrogen replacement therapy to reduce the risk of cancer of the uterus. A woman who has had her uterus removed does not need progestin and should not be treated with this combination medication.

If you need treatment only for vaginal menopause symptoms, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected.

This medication may also be used to prevent bone loss (osteoporosis) in people at high risk who cannot take other drugs that are safe and effective to prevent or treat bone loss (e.g., raloxifene, bisphosphonates such as alendronate). These medicines should be considered for use before estrogen/progestin HRT therapy for osteoporosis.

Common Dosages by Indication:

Atrophic Vaginitis associated with Menopause
Atrophy of Vulva
Post-Menopausal Osteoporosis Prevention
Vasomotor Symptoms associated with Menopause

All Labeled Uses: Atrophic Vaginitis associated with Menopause, Atrophy of Vulva, Post-Menopausal Osteoporosis Prevention, Vasomotor Symptoms associated with Menopause

Premarin® (conjugated estrogens) Tablets, USP

PREMARIN 0.3 MG TABLET

PREMARIN 0.3 MG TABLET

Adult Min/Max Dose: 0.3mg/30.0mg

Common Dosages by Indication:

Atrophic Vaginitis associated with Menopause
take 1 tablet (0.3 mg) po once daily
take 1 tablet (0.3 mg) po once daily for 21 consecutive days, followed by 7 days off
take 1 tablet (0.45 mg) by oral route once daily
take 1 tablet (0.625 mg) by oral route once daily
take 1 tablet (0.625 mg)po once daily for 21 consecutive days, followed by 7 days off
take 1 tablet (0.9 mg) by oral route once daily
take 1 tablet (0.9 mg)po once daily for 21 consecutive days, followed by 7 days off
take 1 tablet (1.25 mg) by oral route once daily
take 1 tablet (1.25 mg) po once daily for 21 consecutive days, followed by 7 days off
Female Hypogonadism
take 1 tablet (1.25 mg) bypo bid for 20 consecutive days, followed by 10 days off
take 2 tablets (2.5 mg) po tid for 20 consecutive days, followed by 10 days off
take 2 tablets (2.5 mg)po tid for 20 consecutive days, followed by 10 days off
take 1 tablet (1.25 mg) po tid for 20 consecutive days, followed by 10 days off
take 1 tablet (2.5 mg) bpo tid for 20 consecutive days, followed by 10 days off
take 1 tablet (2.5 mg) po bid for 20 consecutive days, followed by 10 days off
Hypoestrogenism Due To Bilateral Oophorectomy
take 1 tablet (0.3 mg) by oral route once daily
take 1 tablet (0.3 mg)po once daily for 21 consecutive days, followed by 7 days off
take 1 tablet (0.625 mg) by oral route once daily
take 1 tablet (0.625 mg) po once daily for 21 consecutive days, followed by 7 days off
Metastatic Breast Carcinoma
take 4 tablets (10 mg) by oral route 3 times per day
Post-Menopausal Osteoporosis Prevention
take 1 tablet (0.3 mg) by oral route once daily
take 1 tablet (0.45 mg) by oral route once daily
take 1 tablet (0.45 mg) po once daily for 21 consecutive days, followed by 7 days off
take 1 tablet (0.625 mg) po once daily for 21 consecutive days, followed by 7 days off
Primary Ovarian Failure
take 2 tablets (1.25 mg) by oral route once daily for 21 consecutive days, followed by 7 days off
take 2 tablets (1.25 mg) by oral route once daily
take 1 tablet (1.25 mg) by oral route once daily
take 1 tablet (1.25 mg) by oral route once daily cyclically, 3 weeks on and 1 week off
Prostatic Carcinoma
take 2 tablets (1.25 mg) by oral route 3 times per day
take 2 tablets (1.8 mg) by oral route 3 times per day
take 1 tablet (1.25 mg) by oral route 3 times per day
take 2 tablets (2.5 mg) by oral route 3 times per day
take 1 tablet (2.5 mg) by oral route 3 times per day
Vasomotor Symptoms associated with Menopause
take 1 tablet (0.3 mg) by oral route once daily
take 1 tablet (0.3 mg) po once daily for 21 consecutive days, followed by 7 days off
take 1 tablet (0.45 mg) by oral route once daily
take 1 tablet (0.45 mg) po once daily for 21 consecutive days, followed by 7 days off
take 1 tablet (0.625 mg) by oral route once daily
take 1 tablet (0.625 mg) po once daily for 21 consecutive days, followed by 7 days off
take 1 tablet (0.9 mg) by oral route once daily
take 1 tablet (0.9 mg) po once daily for 21 consecutive days, followed by 7 days off
take 1 tablet (1.25 mg) by oral route once daily
take 1 tablet (1.25 mg) po once daily for 21 consecutive days, followed by 7 days off

All Labeled Uses: Atrophic Vaginitis associated with Menopause, Atrophy of Vulva, Female Hypogonadism, Hypoestrogenism Due To Bilateral Oophorectomy, Metastatic Breast Carcinoma, Post-Menopausal Osteoporosis Prevention, Primary Ovarian Failure, Prostatic Carcinoma, Vasomotor Symptoms associated with Menopause
Unlabeled

Contraindicated Drug Combination:Drug-Drug Interactions

Clearly contraindicated in all cases and should not be dispensed or administered to the same patient:
ESTROGENS/SELECTED ANTI-AROMATASE AGENTS - Decreased effect of the latter drug

Severe Interaction:
Action is required to reduce the risk of severe adverse interaction.
ESTROGENS; CONTRACEPTIVES/RIFAMYCINS - Decreased effect of the former drug
ESTROGEN; CONTRACEPTIVES/ST. JOHN’S WORT - Decreased effect of the former drug

Moderate Interaction:
Assess the risk to the patient and take action as needed.
ESTROGEN/RALOXIFENE - Additive side effects from both drugs
ESTROGENS/BARBITURATES - Decreased effect of the former drug
ESTROGENS/HYDANTOINS - Decreased effect of the former drug
HORMONAL CONTRACEPTIVES; ESTROGENS/CORTICOSTEROIDS - Increased effect of the latter drug
Uses: Pre-Menopausal Osteoporosis

PERCOCET® (oxycodone and acetaminophen) Tablets, USP

HOW TO USE:
Take this medication by mouth, as directed by your doctor. You may take this drug with or without food. If you have nausea, you may take this drug with food, although doing so may decrease its effectiveness. Consult your doctor or pharmacist about alternatives for decreasing nausea (e.g., antihistamines, lying down for 1-2 hours with minimal head movement).

If you are using the liquid form, use a medication measuring device to carefully measure the prescribed dose. Do not use a household spoon because you may not get the correct dose.

SIDE EFFECTS:
Nausea, vomiting, constipation, lightheadedness, dizziness, drowsiness, flushing, vision changes, or mental/mood changes may occur. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.

Related Drugs

PRAVACHOL® (pravastatin sodium) Tablets

PRAVACHOL 10 MG TABLET

PRAVACHOL 10 MG TABLET

PRAVACHOL® (pravastatin sodium) is one of a class of lipid-lowering compounds, the HMG-CoA reductase inhibitors, which reduce cholesterol biosynthesis. These agents are competitive inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase, the enzyme catalyzing the early rate-limiting step in cholesterol biosynthesis, conversion of HMG-CoA to mevalonate.

Adult Patients

The recommended starting dose is 40 mg once daily. If a daily dose of 40 mg does not achieve desired cholesterol levels, 80 mg once daily is recommended. In patients with a history of significant renal or hepatic dysfunction, a starting dose of 10 mg daily is recommended.

Adult Min/Max Dose: 5.0mg/80.0mg

Concomitant Therapy

The lipid-lowering effects of PRAVACHOL on Total- and LDL-cholesterol are enhanced when combined with a bile-acid-binding resin. When administering a bile-acid-binding resin (e.g., cholestyramine, colestipol) and pravastatin, PRAVACHOL should be given either 1 hour or more before or at least 4 hours following the resin.
Common Dosages by Indication:

Arteriosclerotic Vascular Disease
Heterozygous Hypercholesterolemia
Hypercholesterolemia
Hypertriglyceridemia
Mixed Hyperlipidemia
Myocardial Infarction Prevention
Prevention of Cerebrovascular Accident
Prevention of Transient Ischemic Attacks
Primary Dysbetalipoproteinemia
Primary Prevention of Coronary Heart Disease
Slow Progression of Coronary Artery Disease

All Labeled Uses: Arteriosclerotic Vascular Disease, Heterozygous Hypercholesterolemia, Hypercholesterolemia, Hypertriglyceridemia, Mixed Hyperlipidemia, Myocardial Infarction Prevention, Prevention of Cerebrovascular Accident, Prevention of Transient Ischemic Attacks, Primary Dysbetalipoproteinemia, Primary Prevention of Coronary Heart Disease, Slow Progression of Coronary Artery Disease

Drug-Drug Interactions

Severe Interaction:
Action is required to reduce the risk of severe adverse interaction.
SELECTED HMG-COA REDUCTASE INHIBITORS/SELECTED FIBRATES -
HMG-COA REDUCTASE INHIBITORS/CYCLOSPORINE - Increased effect of the former drug
HMG-COA REDUCTASE INHIBITORS/NIACIN - Adverse reaction of the former drug
HMG-COA REDUCTASE INHIBITORS/DAPTOMYCIN - Adverse reaction with both drugs
SELECTED HMG-COA REDUCTASE INHIBITORS/FENOFIBRATE - Adverse reaction with both drugs

Moderate Interaction:
Assess the risk to the patient and take action as needed.
SELECTED HMG-COA REDUCTASE INHIBITORS/RIFAMPIN - Decreased effect of the former drug
PRAVASTATIN/DARUNAVIR - Increased effect of the former drug
SELECTED HMG CO-A REDUCTASE INHIBITORS/EFAVIRENZ - Decreased effect of the former drug
HMG-COA REDUCTASE INHIBITORS/DIGOXIN - Adverse reaction of the former drug
HMG-COA REDUCTASE INHIBIT./COLCHICINE - Additive side effects from both drugs

Plan B® (levonorgestrel) Tablets, 0.75 mg

PLAN B 0.75 MG TABLET

PLAN B 0.75 MG TABLET

Birth Control

Available without a prescription for consumers 18 and older. Rx only for women age 17 and younger

For women age 17 and younger, Plan B® is a prescription-only emergency contraceptive that can be used to prevent pregnancy following unprotected intercourse or a known or suspected contraceptive failure. To obtain optimal efficacy, the first tablet should be taken as soon as possible within 72 hours of intercourse. The second tablet must be taken 12 hours later.

DOSAGE AND ADMINISTRATION

One tablet of Plan B® should be taken orally as soon as possible within 72 hours after unprotected intercourse. The second tablet should be taken 12 hours after the first dose. Efficacy is better if Plan B® is taken as directed as soon as possible after unprotected intercourse. Plan B® can be used at any time during the menstrual cycle.

The user should be instructed that if she vomits within one hour of taking either dose of medication she should contact her health care professional to discuss whether to repeat that dose.

How can I get the best results from Plan B®?

You have only a few days to prevent pregnancy after unprotected sex. Plan B® works better the sooner you take it. Take the first Plan B® tablet as soon as possible but not later than 3 days (72 hours) after unprotected sex. Take the second tablet 12 hours later.

How effective is Plan B®?

Plan B® works best the sooner you use it. If it is taken within 72 hours (3 days) after sex, it will significantly decrease the chance that you will get pregnant. Seven out of every 8 women who would have gotten pregnant will not become pregnant. Plan B® works even better than this if taken within the first 24 hours after sex.

How will I know if Plan B® worked?

Most women will have their next menstrual period at the expected time or within a week of the expected time. If your menstrual period is delayed beyond 1 week, you may be pregnant and you should get a pregnancy test and follow up with your healthcare professional.